gvtcx

NHS Framework Agreement for the supply of Medical Retinal Vascular Treatments

NHS England Published 7 Sept 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£450,000
Statuscomplete
Category (CPV) 33600000
Deadline6 Apr 2022
Contract start1 Aug 2022
Contract end31 Jul 2023
Procedureopen
SME suitableYes
OCIDocds-b5fd17-5886d001-efed-4211-a652-8dcd1992ecd0

Awards (6)

This procurement was awarded to 6 suppliers. Values shown are per-award; the notice total is £450,000.

SupplierValueDateStatus
Abbvie Ltd shared £350,000 25 May 2022 active
Alimera Sciences shared £350,000 25 May 2022 active
Bayer Plc shared £350,000 25 May 2022 active
Novartis Pharmaceuticals UK Ltd shared £350,000 25 May 2022 active
Roche Products Ltd shared £350,000 25 May 2022 active
Teva UK Limited shared £350,000 25 May 2022 active

description

The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
7 Mar 2022 Tender (tender) · 8a741f2e-50b2-4db2-899e-bd3ddad50453-516007
7 Sept 2022 Award (award) · acb80414-da6a-4a87-b1d3-fda017b0e823-569462

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.